[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@galderma GaldermaGalderma posts on X about $gald, investment, $650m, lyft the most. They currently have XXXXX followers and XXX posts still getting attention that total XX engagements in the last XX hours.
Social category influence finance technology brands currencies
Social topic influence $gald #3, investment, $650m, lyft, the face, strong, bases, gain, longterm, the first
Top accounts mentioned or mentioned by @amewzingsj @eadv @cetaphil @prsjournal @ciieonline @alastinskincare @mailonline @drhannahkopelman @drhankopelman @babbleonbrooke @gvenkatesh089 @indianpharmacy @cdsco @indianstandards @prweekuknewsscorporate @pothineni23 @differinus @je3tr0ck @reallovelyjane @punitsingh176
Top posts by engagements in the last XX hours
"Investors are invited to join our Q3 2025 trading update call today Thursday XX at 3:30 PM CET for insights on our record performance: A recording will be made available after the event. #AdvancingDermatology #Q3results $GALD"
X Link 2025-10-23T05:30Z 7179 followers, 3620 engagements
"Were expanding our U.S. presence through strengthening partnerships and increasing overall investment. Our commitment to invest more than $650M in U.S. manufacturing by 2030 is a key way we are building a lasting legacy in dermatology. #AdvancingDermatology #USinvestments"
X Link 2025-10-29T14:47Z 7178 followers, XXX engagements
"Were expanding our research capabilities with the recent openings of our global R&D hub and Skinovation LabTM in the U.S. Were also expanding our teams: our U.S. headcount has grown by almost a third in the last two years. #AdvancingDermatology #USinvestment"
X Link 2025-11-04T08:57Z 7178 followers, XXX engagements
"Restylane Lyft is now FDA approved for use in the chin expanding its versatility across the face and hands. #Restylane #Lyft #Galderma #InjectableAesthetics"
X Link 2025-11-05T06:04Z 7178 followers, XXX engagements
"In 2025 we opened our U.S. and LATAM HQ in Miami and we were delighted to participate in Miamis Key Ceremony this year. We also have a strong presence across the country with bases in Massachusetts California and Texas. #AdvancingDermatology #USinvestment"
X Link 2025-11-10T16:27Z 7178 followers, XXX engagements
"Were excited to be part of #ASDS2025 in Chicago where we will present six scientific posters and host multiple educational sessions. Find out more here: #SkinScienceByGalderma"
X Link 2025-11-12T09:26Z 7178 followers, XXX engagements
"Galderma completes successful placement of CHF XXX million bond. Read more:"
X Link 2025-11-14T06:11Z 7178 followers, XXX engagements
"Exciting new data from #ASDS2025 demonstrate how Restylane and Sculptra are driving innovation in aesthetic medicine. #SkinScienceByGalderma"
X Link 2025-11-17T06:03Z 7178 followers, XXX engagements
"The U.S.-born Galderma Aesthetic Injector Network (GAIN) celebrated its 10-year anniversary by breaking records training more than 10000 healthcare professionals across the U.S. so far this year. #AdvancingDermatology #USinvestment"
X Link 2025-11-19T12:23Z 7178 followers, XXX engagements
"Galderma secures BBB credit rating with positive outlook from S&P Global Ratings. Read more:"
X Link 2025-12-04T06:04Z 7177 followers, XX engagements
"Galderma is expanding patient services in the U.S. Our new multi-million-dollar three-year agreement with AssistRx will expand patient services in the U.S. for patients with prurigo nodularis or moderate-to-severe atopic dermatitis"
X Link 2025-12-04T15:21Z 7177 followers, XX engagements
"Sculptra is evolving. Galdermas latest milestone expands Sculptras clinical application in the EU to the body providing patients with new non-surgical ways to elevate body confidence. Learn more:"
X Link 2025-12-05T06:08Z 7178 followers, XXX engagements
"We are pleased to share that LOral intends to acquire an additional XX% equity investment in Galderma recognizing our scientific leadership in dermatology and long-term growth potential"
X Link 2025-12-08T06:15Z 7178 followers, XXX engagements
"Our record results for Q3 2025 rose to XXXXX billion USD in net sales up XXXX% year-on-year at constant currency. Read more about our progress and recent investments in the U.S. in the press release: #AdvancingDermatology #Q3results $GALD"
X Link 2025-10-23T05:29Z 7179 followers, XXX engagements
"The first patient has been enrolled in our phase II trial in Chronic Pruritus of Unknown Origin a key step toward exploring new science-based approaches for a condition with currently no approved treatments"
X Link 2025-12-11T06:11Z 7179 followers, XXX engagements